Risk Factors for Prognosis in Patients With Severely Decreased GFR

Levin, 2017, Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy, Lancet, 390, 1888, 10.1016/S0140-6736(17)30788-2 Tanner, 2013, Geographic variation in CKD prevalence and ESRD incidence in the United States: results from the reasons for geographic and racial differences in stroke (REGARDS) study, Am J Kidney Dis, 61, 395, 10.1053/j.ajkd.2012.10.018 Zhang, 2012, Prevalence of chronic kidney disease in China: a cross-sectional survey, Lancet, 379, 815, 10.1016/S0140-6736(12)60033-6 Bruck, 2016, CKD prevalence varies across the European general population, J Am Soc Nephrol, 27, 2135, 10.1681/ASN.2015050542 Gasparini, 2016, Prevalence and recognition of chronic kidney disease in Stockholm healthcare, Nephrol Dial Transplant, 31, 2086, 10.1093/ndt/gfw354 Go, 2004, Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization, N Engl J Med, 351, 1296, 10.1056/NEJMoa041031 van der Velde, 2011, Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts, Kidney Int, 79, 1341, 10.1038/ki.2010.536 Tangri, 2011, A predictive model for progression of chronic kidney disease to kidney failure, JAMA, 305, 1553, 10.1001/jama.2011.451 Coresh, 2007, Prevalence of chronic kidney disease in the United States, JAMA, 298, 2038, 10.1001/jama.298.17.2038 Matsushita, 2013, Cohort profile:the chronic kidney disease prognosis consortium, Int J Epidemiol, 42, 1660, 10.1093/ije/dys173 Coresh, 2014, Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality, JAMA, 311, 2518, 10.1001/jama.2014.6634 Levey, 2009, A new equation to estimate glomerular filtration rate, Ann Intern Med, 150, 604, 10.7326/0003-4819-150-9-200905050-00006 Levey, 2007, Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values, Clin Chem, 53, 766, 10.1373/clinchem.2006.077180 Grams, 2016, Kidney-failure risk projection for the living kidney-donor candidate, N Engl J Med, 374, 411, 10.1056/NEJMoa1510491 Borenstein, 2009 Higgins, 2003, Measuring inconsistency in meta-analyses, BMJ, 327, 557, 10.1136/bmj.327.7414.557 Riley, 2011, Interpretation of random effects meta-analyses, BMJ, 342, d549, 10.1136/bmj.d549 Herrington, 2017, Evidence for reverse causality in the association between blood pressure and cardiovascular risk in patients with chronic kidney disease, Hypertension, 69, 314, 10.1161/HYPERTENSIONAHA.116.08386 Schroeder, 2017, Predicting 5-year risk of RRT in stage 3 or 4 CKD: development and external validation, Clin J Am Soc Nephrol, 12, 87, 10.2215/CJN.01290216 Johnson, 2008, Predicting the risk of dialysis and transplant among patients with CKD: a retrospective cohort study, Am J Kidney Dis, 52, 653, 10.1053/j.ajkd.2008.04.026 Yang, 2014, Association of kidney disease outcomes with risk factors for CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) study, Am J Kidney Dis, 63, 236, 10.1053/j.ajkd.2013.08.028 De Nicola, 2011, Prognosis of CKD patients receiving outpatient nephrology care in Italy, Clin J Am Soc Nephrol, 6, 2421, 10.2215/CJN.01180211 Evans, 2005, The natural history of chronic renal failure: results from an unselected, population-based, inception cohort in Sweden, Am J Kidney Dis, 46, 863, 10.1053/j.ajkd.2005.07.040 Lundstrom, 2017, Low renal replacement therapy incidence among slowly progressing elderly chronic kidney disease patients referred to nephrology care:an observational study, BMC Nephrol, 18, 59, 10.1186/s12882-017-0473-1 Hallan, 2012, Age and association of kidney measures with mortality and end-stage renal disease, JAMA, 308, 2349, 10.1001/jama.2012.16817 El-Ghoul, 2009, Nonprogressive kidney dysfunction and outcomes in older adults with chronic kidney disease, J Am Geriatr Soc, 57, 2217, 10.1111/j.1532-5415.2009.02561.x Visser, 2009, Accepting or declining dialysis: considerations taken into account by elderly patients with end-stage renal disease, J Nephrol, 22, 794 Stel, 2009, Residual renal function at the start of dialysis and clinical outcomes, Nephrol Dial Transplant, 24, 3175, 10.1093/ndt/gfp264 Kang, 2004, The impact of gender on progression of renal disease: potential role of estrogen-mediated vascular endothelial growth factor regulation and vascular protection, Am J Pathol, 164, 679, 10.1016/S0002-9440(10)63155-0 Silbiger, 2003, The role of gender in the progression of renal disease, Adv Ren Replace Ther, 10, 3, 10.1053/jarr.2003.50001 Cobo, 2016, Sex and gender differences in chronic kidney disease: progression to end-stage renal disease and haemodialysis, Clin Sci, 130, 1147, 10.1042/CS20160047 Kausz, 2000, Late initiation of dialysis among women and ethnic minorities in the United States, J Am Soc Nephrol, 11, 2351, 10.1681/ASN.V11122351 Coresh, 2005, Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000, J Am Soc Nephrol, 16, 180, 10.1681/ASN.2004070539 Grams, 2013, Lifetime incidence of CKD stages 3–5 in the United States, Am J Kidney Dis, 62, 245, 10.1053/j.ajkd.2013.03.009 McClellan, 2006, Racial differences in the prevalence of chronic kidney disease among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort Study, J Am Soc Nephrol, 17, 1710, 10.1681/ASN.2005111200 Parsa, 2013, APOL1 risk variants, race, and progression of chronic kidney disease, N Engl J Med, 369, 2183, 10.1056/NEJMoa1310345 Naik, 2014, Association of sickle cell trait with chronic kidney disease and albuminuria in African Americans, JAMA, 312, 2115, 10.1001/jama.2014.15063 Fox, 2004, Predictors of new-onset kidney disease in a community-based population, JAMA, 291, 844, 10.1001/jama.291.7.844 D'Agostino, 2008, General cardiovascular risk profile for use in primary care: The Framingham Heart Study, Circulation, 117, 743, 10.1161/CIRCULATIONAHA.107.699579 Haroun, 2003, Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County, Maryland. J Am Soc Nephrol, 14, 2934, 10.1097/01.ASN.0000095249.99803.85 Tangri, 2016, Multinational assessment of accuracy of equations for predicting risk of kidney failure: a meta-analysis, JAMA, 315, 164, 10.1001/jama.2015.18202 Bolignano, 2017, Non-proteinuric rather than proteinuric renal diseases are the leading cause of end-stage kidney disease, Nephrol Dial Transplant, 32, ii194, 10.1093/ndt/gfw440 Carrero, 2017, Albuminuria changes are associated with subsequent risk of end-stage renal disease and mortality, Kidney Int, 91, 244, 10.1016/j.kint.2016.09.037 Xia, 2017, Cigarette smoking and chronic kidney disease in the general population: a systematic review and meta-analysis of prospective cohort studies, Nephrol Dial Transplant, 32, 475, 10.1093/ndt/gfw452 Staplin, 2016, Smoking and adverse outcomes in patients with CKD: The Study of Heart and Renal Protection (SHARP), Am J Kidney Dis, 68, 371, 10.1053/j.ajkd.2016.02.052 Peralta, 2012, Blood pressure components and end-stage renal disease in persons with chronic kidney disease:the Kidney Early Evaluation Program (KEEP), Arch Intern Med, 172, 41, 10.1001/archinternmed.2011.619 Xie, 2016, Effects of intensive blood pressure lowering on cardiovascular and renal outcomes:updated systematic review and meta-analysis, Lancet, 387, 435, 10.1016/S0140-6736(15)00805-3 Grams ME, Sang Y, Ballew SH, et al. Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate [e-pub ahead of print]. Kidney Int. https://doi.org/10.1016/j.kint.2018.01.009.